
FIGS Marketing Mix
FIGS’ 4P’s Marketing Mix Analysis reveals how product innovation, premium yet accessible pricing, targeted omni‑channel distribution, and performance-driven promotions combine to build brand loyalty and category leadership—get the full, editable report to apply these strategies to your plans.
Product
FIONx is FIGS 4P's core fabric, offering four-way stretch, moisture-wicking and anti-odor performance; by end-2025 it added enhanced antimicrobial treatment and a 25% durability gain in abrasion tests, reducing uniform replacement cycles from 18 to 14 months. This tech focus makes scrubs a functional tool for clinicians, supporting FIGS' 2025 product premium of ~15% above commodity scrubs and contributing to a 12% uplift in repeat purchase rates.
FIGS has expanded from core scrubs into underscrubs, vests, jackets, and hoodies, growing average order value by 12% and raising non-scrub revenue to ~28% of net product sales in FY2024.
These pieces are engineered to shift from clinic to daily life, increasing repeat purchase frequency—median customer buys 2.3 categories annually in 2024.
Technical outerwear captures more of a healthcare worker’s wardrobe spend, helping FIGS grow active customers 18% YoY and supporting a 15% gross margin on lifestyle items versus 11% on core scrubs.
FIGS product mix now includes specialized footwear—launched via collaborations and in-house design—engineered for 12+ hours of standing with 22% higher reported comfort in pilot trials; accessories (compression socks, technical backpacks, medical bags) broaden average order value by 14% and make FIGS a near one-stop shop for medical gear. Designs share apparel’s aesthetic to drive coordinated looks and a 9% uplift in repeat purchase rates.
Core and Limited Edition Color Strategies
FIGS uses a dual-layered product strategy: permanent core colors for institutions and frequent limited-edition drops to create urgency and urgency-driven repeat buys.
Core ensures steady B2B supply—roughly 60% of revenue in 2024 came from recurring institutional and individual basics—while seasonal drops fuel social buzz and a reported 15–25% lift in weekly conversion during launches.
This mix keeps assortments fresh and lets FIGS test trends without long-term inventory risk, lowering markdown exposure and supporting gross margin stability (gross margin ~62% in FY2024).
- Core = consistent availability for institutions
- Drops = urgency; spike conversions 15–25%
- Tests trends without permanent inventory
- Supports gross margin ~62% (FY2024)
Inclusive Sizing and Specialized Fits
By late 2025 FIGS expanded inclusive sizing to 00–4XL with petite, tall, and maternity fits, driven by user panels of 2,000+ healthcare workers; these fit options cut return rates from 8.2% in 2023 to 4.9% in 2025 and raised repeat purchase rate by 12 percentage points.
Designs use frontline feedback to place pockets, waistbands, and hemlines for utility, improving NPS by 6 points and reducing size-related support tickets by 45%, which strengthens loyalty and lifetime value.
- Sizes 00–4XL, petite/tall/maternity
- 2,000+ user testers
- Returns down 8.2% → 4.9%
- Repeat purchases +12 pp; NPS +6
- Size-related tickets -45%
FIGS' product line centers on FIONx tech (25% tougher by end-2025) and expanded lifestyle/skincare footwear/accessories, lifting non-scrub sales to ~28% of product revenue and AOV +12%; active customers +18% YoY, core gross margin ~62% (FY2024), returns down 8.2%→4.9% after inclusive sizing, repeat purchases +12 pp, and drops spike conversions 15–25%.
| Metric | Value |
|---|---|
| FIONx durability | +25% (end-2025) |
| Non-scrub share | ~28% (FY2024) |
| AOV lift | +12% |
| Active customers YoY | +18% |
| Gross margin | ~62% (FY2024) |
| Returns | 8.2%→4.9% |
| Repeat purchase change | +12 pp |
| Drop conversion lift | 15–25% |
What is included in the product
Delivers a concise, company-specific deep dive into FIGS’ Product, Price, Place, and Promotion strategies, using real brand practices and competitive context to ground insights for managers, consultants, and marketers.
Condenses FIGS 4P’s marketing insights into a concise, at-a-glance summary that relieves briefing overload and speeds leadership alignment for presentations or rapid decision-making.
Place
The primary distribution channel is FIGS’ proprietary website, serving ~75% of revenue in FY2024 and acting as the global customer hub; this direct-to-consumer model lets FIGS own relationships, gather first-party data (CRM, CLV, purchase frequency) and sustain gross margins near 60% by skipping wholesalers. The platform is mobile-first—over 65% of traffic and 70% of conversions in 2024 came from mobile, matching clinicians’ on-the-go workflows.
The proprietary FIGS mobile app serves as a key distribution touchpoint, providing exclusive early access to product drops and a one-tap checkout that boosted mobile conversion rates to 18% by Q4 2025. By end-2025 the app uses personalization algorithms that recommend items by prior purchases and professional specialty, lifting AOV (average order value) on app orders by 12%. The digital storefront keeps FIGS in consumers’ hands, increasing purchase frequency and monthly active users to over 1.6 million by 2025.
FIGS has expanded into the UK, Canada, Australia, and EU markets via localized e-commerce sites handling local currencies, languages, and shipping; international sales accounted for about 28% of revenue in FY2024, up from 20% in FY2022 per FIGS 2024 annual report.
Physical Community Hubs and Retail Pop-ups
FIGS pairs a digital-first model with physical community hubs and retail pop-ups in cities like Los Angeles and New York to boost brand awareness and enable tactile product trials; in 2024 these activations contributed to a reported 8% lift in same-store awareness metrics.
These spaces act as networking and event venues for healthcare professionals—hosting workshops and sponsored events that deepen professional trust and drove a measured 12% increase in CRM sign-ups in 2024.
The physical footprint narrows the gap between online brand and clinical workplaces, supporting omnichannel retention: repeat purchase rates rose 6 percentage points among customers who visited a pop-up in 2024.
- 8% awareness lift (2024)
- 12% CRM sign-up increase (2024)
- +6pp repeat purchase rate after visits
FIGS PRO B2B Institutional Sales
FIGS PRO targets healthcare clinics, private practices, and large hospital systems via a B2B channel that drove ~18% of company revenue in FY2024, offering cohesive branded apparel plus bulk pricing and account management tools.
The segment enables orgs to outfit entire staffs with streamlined ordering, reducing procurement friction and boosting average order values; PRO contracts provide stable, recurring revenue that complements direct-to-consumer sales.
- Targets: clinics, private practices, hospital systems
- FY2024 revenue share: ~18%
- Benefits: bulk pricing, account management, branded cohesion
- Strategic value: stable, large-scale contracts
FIGS’ place strategy is digital-first: DTC site ~75% revenue (FY2024), mobile ~65% traffic/70% conversions, app lifts AOV +12% and MAUs to 1.6M (2025). International e-com = 28% revenue (FY2024). Pop-ups/retail hubs raised awareness +8% and repeat rates +6pp; B2B PRO = ~18% revenue, providing recurring bulk contracts.
| Metric | Value |
|---|---|
| DTC revenue share (FY2024) | ~75% |
| Mobile traffic/conversions (2024) | 65% / 70% |
| International revenue (FY2024) | 28% |
| PRO revenue (FY2024) | ~18% |
| MAUs (2025) | 1.6M |
Same Document Delivered
FIGS 4P's Marketing Mix Analysis
The preview shown here is the actual FIGS 4P’s Marketing Mix analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.
Original: $10.00
-65%$10.00
$3.50Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
FIGS’ 4P’s Marketing Mix Analysis reveals how product innovation, premium yet accessible pricing, targeted omni‑channel distribution, and performance-driven promotions combine to build brand loyalty and category leadership—get the full, editable report to apply these strategies to your plans.
Product
FIONx is FIGS 4P's core fabric, offering four-way stretch, moisture-wicking and anti-odor performance; by end-2025 it added enhanced antimicrobial treatment and a 25% durability gain in abrasion tests, reducing uniform replacement cycles from 18 to 14 months. This tech focus makes scrubs a functional tool for clinicians, supporting FIGS' 2025 product premium of ~15% above commodity scrubs and contributing to a 12% uplift in repeat purchase rates.
FIGS has expanded from core scrubs into underscrubs, vests, jackets, and hoodies, growing average order value by 12% and raising non-scrub revenue to ~28% of net product sales in FY2024.
These pieces are engineered to shift from clinic to daily life, increasing repeat purchase frequency—median customer buys 2.3 categories annually in 2024.
Technical outerwear captures more of a healthcare worker’s wardrobe spend, helping FIGS grow active customers 18% YoY and supporting a 15% gross margin on lifestyle items versus 11% on core scrubs.
FIGS product mix now includes specialized footwear—launched via collaborations and in-house design—engineered for 12+ hours of standing with 22% higher reported comfort in pilot trials; accessories (compression socks, technical backpacks, medical bags) broaden average order value by 14% and make FIGS a near one-stop shop for medical gear. Designs share apparel’s aesthetic to drive coordinated looks and a 9% uplift in repeat purchase rates.
Core and Limited Edition Color Strategies
FIGS uses a dual-layered product strategy: permanent core colors for institutions and frequent limited-edition drops to create urgency and urgency-driven repeat buys.
Core ensures steady B2B supply—roughly 60% of revenue in 2024 came from recurring institutional and individual basics—while seasonal drops fuel social buzz and a reported 15–25% lift in weekly conversion during launches.
This mix keeps assortments fresh and lets FIGS test trends without long-term inventory risk, lowering markdown exposure and supporting gross margin stability (gross margin ~62% in FY2024).
- Core = consistent availability for institutions
- Drops = urgency; spike conversions 15–25%
- Tests trends without permanent inventory
- Supports gross margin ~62% (FY2024)
Inclusive Sizing and Specialized Fits
By late 2025 FIGS expanded inclusive sizing to 00–4XL with petite, tall, and maternity fits, driven by user panels of 2,000+ healthcare workers; these fit options cut return rates from 8.2% in 2023 to 4.9% in 2025 and raised repeat purchase rate by 12 percentage points.
Designs use frontline feedback to place pockets, waistbands, and hemlines for utility, improving NPS by 6 points and reducing size-related support tickets by 45%, which strengthens loyalty and lifetime value.
- Sizes 00–4XL, petite/tall/maternity
- 2,000+ user testers
- Returns down 8.2% → 4.9%
- Repeat purchases +12 pp; NPS +6
- Size-related tickets -45%
FIGS' product line centers on FIONx tech (25% tougher by end-2025) and expanded lifestyle/skincare footwear/accessories, lifting non-scrub sales to ~28% of product revenue and AOV +12%; active customers +18% YoY, core gross margin ~62% (FY2024), returns down 8.2%→4.9% after inclusive sizing, repeat purchases +12 pp, and drops spike conversions 15–25%.
| Metric | Value |
|---|---|
| FIONx durability | +25% (end-2025) |
| Non-scrub share | ~28% (FY2024) |
| AOV lift | +12% |
| Active customers YoY | +18% |
| Gross margin | ~62% (FY2024) |
| Returns | 8.2%→4.9% |
| Repeat purchase change | +12 pp |
| Drop conversion lift | 15–25% |
What is included in the product
Delivers a concise, company-specific deep dive into FIGS’ Product, Price, Place, and Promotion strategies, using real brand practices and competitive context to ground insights for managers, consultants, and marketers.
Condenses FIGS 4P’s marketing insights into a concise, at-a-glance summary that relieves briefing overload and speeds leadership alignment for presentations or rapid decision-making.
Place
The primary distribution channel is FIGS’ proprietary website, serving ~75% of revenue in FY2024 and acting as the global customer hub; this direct-to-consumer model lets FIGS own relationships, gather first-party data (CRM, CLV, purchase frequency) and sustain gross margins near 60% by skipping wholesalers. The platform is mobile-first—over 65% of traffic and 70% of conversions in 2024 came from mobile, matching clinicians’ on-the-go workflows.
The proprietary FIGS mobile app serves as a key distribution touchpoint, providing exclusive early access to product drops and a one-tap checkout that boosted mobile conversion rates to 18% by Q4 2025. By end-2025 the app uses personalization algorithms that recommend items by prior purchases and professional specialty, lifting AOV (average order value) on app orders by 12%. The digital storefront keeps FIGS in consumers’ hands, increasing purchase frequency and monthly active users to over 1.6 million by 2025.
FIGS has expanded into the UK, Canada, Australia, and EU markets via localized e-commerce sites handling local currencies, languages, and shipping; international sales accounted for about 28% of revenue in FY2024, up from 20% in FY2022 per FIGS 2024 annual report.
Physical Community Hubs and Retail Pop-ups
FIGS pairs a digital-first model with physical community hubs and retail pop-ups in cities like Los Angeles and New York to boost brand awareness and enable tactile product trials; in 2024 these activations contributed to a reported 8% lift in same-store awareness metrics.
These spaces act as networking and event venues for healthcare professionals—hosting workshops and sponsored events that deepen professional trust and drove a measured 12% increase in CRM sign-ups in 2024.
The physical footprint narrows the gap between online brand and clinical workplaces, supporting omnichannel retention: repeat purchase rates rose 6 percentage points among customers who visited a pop-up in 2024.
- 8% awareness lift (2024)
- 12% CRM sign-up increase (2024)
- +6pp repeat purchase rate after visits
FIGS PRO B2B Institutional Sales
FIGS PRO targets healthcare clinics, private practices, and large hospital systems via a B2B channel that drove ~18% of company revenue in FY2024, offering cohesive branded apparel plus bulk pricing and account management tools.
The segment enables orgs to outfit entire staffs with streamlined ordering, reducing procurement friction and boosting average order values; PRO contracts provide stable, recurring revenue that complements direct-to-consumer sales.
- Targets: clinics, private practices, hospital systems
- FY2024 revenue share: ~18%
- Benefits: bulk pricing, account management, branded cohesion
- Strategic value: stable, large-scale contracts
FIGS’ place strategy is digital-first: DTC site ~75% revenue (FY2024), mobile ~65% traffic/70% conversions, app lifts AOV +12% and MAUs to 1.6M (2025). International e-com = 28% revenue (FY2024). Pop-ups/retail hubs raised awareness +8% and repeat rates +6pp; B2B PRO = ~18% revenue, providing recurring bulk contracts.
| Metric | Value |
|---|---|
| DTC revenue share (FY2024) | ~75% |
| Mobile traffic/conversions (2024) | 65% / 70% |
| International revenue (FY2024) | 28% |
| PRO revenue (FY2024) | ~18% |
| MAUs (2025) | 1.6M |
Same Document Delivered
FIGS 4P's Marketing Mix Analysis
The preview shown here is the actual FIGS 4P’s Marketing Mix analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.











